Chapter 1. Bioinformatics Drug Discovery Services Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources 
Chapter 2. Bioinformatics Drug Discovery Services Market – Executive Summary
2.1    Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
              2.2.1    Demand Side
              2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. Bioinformatics Drug Discovery Services Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis 
Chapter 4. Bioinformatics Drug Discovery Services Market - Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
              4.5.1    Bargaining Power of Suppliers
              4.5.2    Bargaining Powers of Customers
              4.5.3    Threat of New Entrants
              4.5.4    Rivalry among Existing Players
              4.5.5    Threat of Substitutes 
Chapter 5. Bioinformatics Drug Discovery Services Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Bioinformatics Drug Discovery Services Market – By Application
6.1    Introduction/Key Findings   
6.2    Oncology
6.3    Cardiovascular Diseases
6.4    Neurology
6.5    Infectious Diseases
6.6    Others
6.7    Y-O-Y Growth trend Analysis By Application
6.8    Absolute $ Opportunity Analysis By Application, 2024-2030 
Chapter 7. Bioinformatics Drug Discovery Services Market – By End User
7.1    Introduction/Key Findings   
7.2    Research Laboratories and Academic Institutes
7.3    Pharmaceutical and Biotechnology Companies
7.4    Contract Research Organizations (CROs)
7.5    Hospitals and Diagnostic Centers
7.6    Y-O-Y Growth  trend Analysis By End User
7.7    Absolute $ Opportunity Analysis By End User, 2024-2030  
Chapter 8. Bioinformatics Drug Discovery Services Market , By Geography – Market Size, Forecast, Trends & Insights
8.1    North America
              8.1.1    By Country
                            8.1.1.1    U.S.A.
                            8.1.1.2    Canada
                            8.1.1.3    Mexico
              8.1.2    By Application
              8.1.3    By End User
              8.1.4    Countries & Segments - Market Attractiveness Analysis
8.2    Europe
              8.2.1    By Country
                            8.2.1.1    U.K
                            8.2.1.2    Germany
                            8.2.1.3    France
                            8.2.1.4    Italy
                            8.2.1.5    Spain
                            8.2.1.6    Rest of Europe
              8.2.2    By Application
              8.2.3    By End User
              8.2.4    Countries & Segments - Market Attractiveness Analysis
8.3    Asia Pacific
              8.3.1    By Country
                            8.3.1.1    China
                            8.3.1.2    Japan
                            8.3.1.3    South Korea
                            8.3.1.4    India      
                            8.3.1.5    Australia & New Zealand
                            8.3.1.6    Rest of Asia-Pacific
              8.3.2    By Application
              8.3.3    By End User
              8.3.4    Countries & Segments - Market Attractiveness Analysis
8.4    South America
              8.4.1    By Country
                            8.4.1.1    Brazil
                            8.4.1.2    Argentina
                            8.4.1.3    Colombia
                            8.4.1.4    Chile
                            8.4.1.5    Rest of South America
              8.4.2    By Application
              8.4.3    By End User
              8.4.4    Countries & Segments - Market Attractiveness Analysis
8.5    Middle East & Africa
              8.5.1    By Country
                            8.5.1.1    United Arab Emirates (UAE)
                            8.5.1.2    Saudi Arabia
                            8.5.1.3    Qatar
                            8.5.1.4    Israel
                            8.5.1.5    South Africa
                            8.5.1.6    Nigeria
                            8.5.1.7    Kenya
                            8.5.1.8    Egypt
                            8.5.1.9    Rest of MEA
              8.5.2    By Application
              8.5.3    By End User
              8.5.4    Countries & Segments - Market Attractiveness Analysis 
Chapter 9. Bioinformatics Drug Discovery Services Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
9.1    Schrödinger
9.2    Genedata
9.3    Certara
9.4    Collaborative Drug Discovery (CDD)
9.5    Atomwise
9.6    Insilico Medicine
9.7    Numerate
9.8    Acellera
9.9    Biovista
9.10    ChemAxon